BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 14978995)

  • 1. Controversies about the treatment of hepatitis B (lamivudine, interferon, a combination or more?).
    Desai HG; Chowdhury A
    Trop Gastroenterol; 2003; 24(3):157-60. PubMed ID: 14978995
    [No Abstract]   [Full Text] [Related]  

  • 2. Adefovir-lamivudine combination therapy and hepatitis B viral kinetics.
    Mutimer D
    J Hepatol; 2005 Aug; 43(2):200-2. PubMed ID: 15975684
    [No Abstract]   [Full Text] [Related]  

  • 3. Adefovir dipivoxil to prevent exacerbation of lamivudine-resistant hepatitis B infection during chemotherapy for non-Hodgkin's lymphoma.
    Enomoto M; Nishiguchi S; Seki S; Yamane T; Hino M
    Am J Gastroenterol; 2004 Aug; 99(8):1619-20. PubMed ID: 15307884
    [No Abstract]   [Full Text] [Related]  

  • 4. Hepatitis B virus kinetics and mathematical modeling.
    Perelson AS; Ribeiro RM
    Semin Liver Dis; 2004; 24 Suppl 1():11-6. PubMed ID: 15192796
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Current treatment of hepatitis B].
    Suárez García E; Romero Gómez M; Grande Santamaría L
    Gastroenterol Hepatol; 2001 Feb; 24 Suppl 1():35-50. PubMed ID: 11279893
    [No Abstract]   [Full Text] [Related]  

  • 6. Management of the patient with hepatitis B virus-related cirrhosis.
    Perrillo RP
    J Hepatol; 2003; 39 Suppl 1():S177-80. PubMed ID: 14708700
    [No Abstract]   [Full Text] [Related]  

  • 7. Combination therapy for chronic hepatitis B.
    Schalm SW
    J Hepatol; 2003; 39 Suppl 1():S146-50. PubMed ID: 14708694
    [No Abstract]   [Full Text] [Related]  

  • 8. [New developments in therapy of chronic hepatitis B. When are nucleoside analogs indicated?].
    Petry W; Erhardt A; Heintges T; Häussinger D
    Z Gastroenterol; 2000 Jan; 38(1):77-87. PubMed ID: 10689749
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [New option for successful therapy of chronic hepatitis B].
    Ortleb J
    Dtsch Med Wochenschr; 2003 Jul; 128(28-29):1565. PubMed ID: 12899163
    [No Abstract]   [Full Text] [Related]  

  • 10. Incidental treatment of hepatitis B virus infection in an AIDS patient.
    Warner D
    AIDS Read; 2000 Jun; 10(6):376. PubMed ID: 10881369
    [No Abstract]   [Full Text] [Related]  

  • 11. [Treating chronic lamivudine-resistant hepatitis B in HIV co-infected patients].
    Benhamou Y
    Gastroenterol Clin Biol; 2006 Oct; 30(10 Pt 2):3S22-5. PubMed ID: 17075492
    [No Abstract]   [Full Text] [Related]  

  • 12. Tenofovir disoproxil fumarate exhibits strong antiviral effect in a patient with lamivudine-resistant severe hepatitis B reactivation.
    Van Bömmel F; Schernick A; Hopf U; Berg T
    Gastroenterology; 2003 Feb; 124(2):586-7. PubMed ID: 12557178
    [No Abstract]   [Full Text] [Related]  

  • 13. [New antiviral agent. Hepatitis B therapy with slight resistance risk].
    MMW Fortschr Med; 2003 Dec; 145(51-52):40. PubMed ID: 14974332
    [No Abstract]   [Full Text] [Related]  

  • 14. [Current knowledge on chronic hepatitis B therapy].
    Zoulim F; Werle B
    Gastroenterol Clin Biol; 2001 Apr; 25(4 Suppl):B143-51. PubMed ID: 11449155
    [No Abstract]   [Full Text] [Related]  

  • 15. Combined interferon plus lamivudine treatment in young patients with dual HBV (HBeAg positive) and HCV chronic infection.
    Marrone A; Zampino R; D'Onofrio M; Ricciotti R; Ruggiero G; Utili R
    J Hepatol; 2004 Dec; 41(6):1064-5. PubMed ID: 15582146
    [No Abstract]   [Full Text] [Related]  

  • 16. Management of patients with decompensated HBV cirrhosis.
    Fontana RJ
    Semin Liver Dis; 2003 Feb; 23(1):89-100. PubMed ID: 12616454
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Managing lamivudine resistance in liver transplantation for hepatitis B liver disease].
    Samuel D
    Gastroenterol Clin Biol; 2006 Oct; 30(10 Pt 2):3S26-30. PubMed ID: 17075493
    [No Abstract]   [Full Text] [Related]  

  • 18. Therapeutic options for chronic hepatitis B: considerations and controversies.
    Jacobson IM
    Am J Gastroenterol; 2006; 101 Suppl 1():S13-8. PubMed ID: 16448447
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatitis B: the pathway to recovery through treatment.
    Hollinger FB; Lau DT
    Gastroenterol Clin North Am; 2006 Jun; 35(2):425-61, x. PubMed ID: 16880074
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Managing resistance to analogue antiviral drugs in a decompensated cirrhosis patient].
    Zarski JP
    Gastroenterol Clin Biol; 2006 Oct; 30(10 Pt 2):3S20-1. PubMed ID: 17075491
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.